Dianna J Magliano

Summary

Affiliation: International Diabetes Institute
Country: Australia

Publications

  1. ncbi How to best define the metabolic syndrome
    Dianna J Magliano
    International Diabetes Institute, Melbourne, Australia
    Ann Med 38:34-41. 2006
  2. ncbi Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study
    Dianna J Magliano
    International Diabetes Institute, 250 Kooyong Rd, Caulfield, Victoria, 3162, Australia
    Diabetes Care 31:267-72. 2008
  3. ncbi HPLC-detected albuminuria predicts mortality
    Dianna J Magliano
    International Diabetes Institute, Melbourne, Victoria, Australia
    J Am Soc Nephrol 18:3171-6. 2007
  4. ncbi Health and mortality consequences of abdominal obesity: evidence from the AusDiab study
    Adrian J Cameron
    Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia
    Med J Aust 191:202-8. 2009
  5. ncbi Explaining the increase of diabetes prevalence and plasma glucose in Mauritius
    Dianna J Magliano
    Baker IDI Heart and Diabetes Institute, Melbourne, Australia
    Diabetes Care 35:87-91. 2012
  6. ncbi Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
    Elizabeth L M Barr
    International Diabetes Institute, 250 Kooyong Rd, Caulfield, Victoria, 3162, Australia
    Circulation 116:151-7. 2007
  7. ncbi Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study
    Robin M Daly
    Centre for Physical Activity and Nutrition Research, School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia
    Clin Endocrinol (Oxf) 77:26-35. 2012
  8. ncbi Projected progression of the prevalence of obesity in Australia
    Helen L Walls
    Department of Epidemiology and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia
    Obesity (Silver Spring) 20:872-8. 2012
  9. ncbi AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures
    Lei Chen
    Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic, Australia
    Med J Aust 192:197-202. 2010
  10. ncbi How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000
    Lei Chen
    Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic, Australia
    Med J Aust 189:319-22. 2008

Detail Information

Publications32

  1. ncbi How to best define the metabolic syndrome
    Dianna J Magliano
    International Diabetes Institute, Melbourne, Australia
    Ann Med 38:34-41. 2006
    ..It is envisaged that the development of the new definition for the metabolic syndrome will help resolve the confusion caused by the number of earlier attempts to define this important entity...
  2. ncbi Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study
    Dianna J Magliano
    International Diabetes Institute, 250 Kooyong Rd, Caulfield, Victoria, 3162, Australia
    Diabetes Care 31:267-72. 2008
    ..This national, population-based study reports diabetes incidence based on oral glucose tolerance tests (OGTTs) and identifies risk factors for diabetes in Australians...
  3. ncbi HPLC-detected albuminuria predicts mortality
    Dianna J Magliano
    International Diabetes Institute, Melbourne, Victoria, Australia
    J Am Soc Nephrol 18:3171-6. 2007
    ..We conclude that albuminuria, detected by either IN or HPLC, independently predicts mortality in a community-based sample. HPLC identifies some people at increased risk of mortality that IN would not detect...
  4. ncbi Health and mortality consequences of abdominal obesity: evidence from the AusDiab study
    Adrian J Cameron
    Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia
    Med J Aust 191:202-8. 2009
    ..To provide an estimate of the morbidity and mortality resulting from abdominal overweight and obesity in the Australian population...
  5. ncbi Explaining the increase of diabetes prevalence and plasma glucose in Mauritius
    Dianna J Magliano
    Baker IDI Heart and Diabetes Institute, Melbourne, Australia
    Diabetes Care 35:87-91. 2012
    ....
  6. ncbi Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
    Elizabeth L M Barr
    International Diabetes Institute, 250 Kooyong Rd, Caulfield, Victoria, 3162, Australia
    Circulation 116:151-7. 2007
    ..This study investigated whether impaired fasting glucose and impaired glucose tolerance, as well as diabetes mellitus, increase the risk of all-cause and CVD mortality...
  7. ncbi Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study
    Robin M Daly
    Centre for Physical Activity and Nutrition Research, School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia
    Clin Endocrinol (Oxf) 77:26-35. 2012
    ..This study evaluated the vitamin D status of Australian adults aged ≥25 years and risk factors associated with vitamin D deficiency in this population. Design and..
  8. ncbi Projected progression of the prevalence of obesity in Australia
    Helen L Walls
    Department of Epidemiology and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia
    Obesity (Silver Spring) 20:872-8. 2012
    ....
  9. ncbi AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures
    Lei Chen
    Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic, Australia
    Med J Aust 192:197-202. 2010
    ..To develop and validate a diabetes risk assessment tool for Australia based on demographic, lifestyle and simple anthropometric measures...
  10. ncbi How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000
    Lei Chen
    Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic, Australia
    Med J Aust 189:319-22. 2008
    ....
  11. ncbi The influence of hip circumference on the relationship between abdominal obesity and mortality
    Adrian J Cameron
    Clinical Diabetes and Epidemiology, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    Int J Epidemiol 41:484-94. 2012
    ..We hypothesized that adding waist and hip circumference to traditional risk factors would significantly improve CVD risk prediction...
  12. ncbi The effect of modifiable risk factors on geographic mortality differentials: a modelling study
    Christopher E Stevenson
    School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, 99 Commercial Road, Melbourne, Victoria, Australia
    BMC Public Health 12:79. 2012
    ..Australian mortality rates are higher in regional and remote areas than in major cities. The degree to which this is driven by variation in modifiable risk factors is unknown...
  13. ncbi Area-level socioeconomic status and incidence of abnormal glucose metabolism: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study
    Emily D Williams
    School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
    Diabetes Care 35:1455-61. 2012
    ..To examine the role of area-level socioeconomic status (SES) on the development of abnormal glucose metabolism (AGM) using national, population-based data...
  14. ncbi Frequent walking, but not total physical activity, is associated with increased fracture incidence: a 5-year follow-up of an Australian population-based prospective study (AusDiab)
    Riku Nikander
    Department of Medicine, NorthWest Academic Centre, University of Melbourne, Western Hospital, Melbourne, Australia
    J Bone Miner Res 26:1638-47. 2011
    ..In conclusion, older adults who adhered to the current PA guidelines were not protected against fragility fractures, but more frequent walking was associated with an increased fracture risk...
  15. ncbi Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study
    Lei Chen
    Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    Eur J Cardiovasc Prev Rehabil 14:740-5. 2007
    ..We aimed to establish the most appropriate anthropometric index and its optimal cutoff point for use as an ancillary measure in clinical practice when identifying people with increased absolute cardiovascular risk estimates...
  16. ncbi 25-hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study
    Matthew J Damasiewicz
    Department of Nephrology, Monash Medical Centre, 246 Clayton Road, Clayton, 3168, Victoria, Australia
    BMC Nephrol 13:55. 2012
    ..We explored the relationship between 25(OH)D levels and prevalent chronic kidney disease (CKD), albuminuria and impaired GFR, in a national, population-based cohort of Australian adults (AusDiab Study)...
  17. ncbi The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model
    Ella Zomer
    CCRE Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, The Alfred Centre, Melbourne, Victoria, Australia
    BMJ 344:e3657. 2012
    ..To model the long term effectiveness and cost effectiveness of daily dark chocolate consumption in a population with metabolic syndrome at high risk of cardiovascular disease...
  18. ncbi Trends in BMI of urban Australian adults, 1980-2000
    Helen L Walls
    Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Victoria 3004, Australia
    Public Health Nutr 13:631-8. 2010
    ..To analyse changes in the distribution of BMI in Australia between 1980 and 2000...
  19. ncbi The metabolic syndrome in Australia: prevalence using four definitions
    Adrian J Cameron
    International Diabetes Institute, 250 Kooyong Road, Caulfield, Melbourne, Victoria 3162, Australia
    Diabetes Res Clin Pract 77:471-8. 2007
    ..To compare the prevalence of the Metabolic Syndrome (MetS) defined by four definitions and to determine which definition best identifies those at high cardiovascular disease (CVD) risk and with insulin resistance...
  20. ncbi Associations of strength training with impaired glucose metabolism: the AusDiab Study
    Karl E Minges
    Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    Med Sci Sports Exerc 45:299-303. 2013
    ..To examine the association of strength training (ST) activity with impaired glucose metabolism (IGM) in Australian adults...
  21. ncbi Projected socioeconomic disparities in the prevalence of obesity among Australian adults
    Kathryn Backholer
    Department of Epidemiology and Preventive Medicine, Monash University, Victoria, Australia
    Aust N Z J Public Health 36:557-63. 2012
    ....
  22. ncbi Diabetes prevalence and determinants in Indigenous Australian populations: A systematic review
    Karl E Minges
    Baker IDI Heart and Diabetes Institute, Melbourne, Australia
    Diabetes Res Clin Pract 93:139-49. 2011
    ..To perform a systematic review of the prevalence of diabetes and impaired glucose tolerance (IGT) in Indigenous Australians in order to clarify overall patterns, by determinants such as age, gender, region, ethnicity and remoteness...
  23. ncbi Setting population targets for measuring successful obesity prevention
    Kathryn Backholer
    Department of Epidemiology and Preventive Medicine, Monash University, Victoria, Melbourne, Australia
    Am J Public Health 100:2033-7. 2010
    ..A reliable model of future body weight prevalence is critical to set, evaluate, and monitor national obesity targets...
  24. ncbi Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study
    Dianna J Magliano
    Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    Eur J Endocrinol 167:589-99. 2012
    ..To explore the relationship between diabetes and cancer...
  25. ncbi Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose tolerance
    Dianna J Magliano
    Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    Diabetes Care 33:1983-9. 2010
    ..We explored this issue in a large, multiethnic cohort from the developing nation of Mauritius...
  26. ncbi The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives
    Lei Chen
    Baker IDI Heart and Diabetes Institute, 99 Commercial Road, Melbourne, VIC 3004, Australia
    Nat Rev Endocrinol 8:228-36. 2012
    ..The potential effect on global diabetes surveillance of using HbA(1c) rather than glucose values in the diagnosis of T2DM is also discussed...
  27. ncbi Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study)
    Claudia Gagnon
    Department of Medicine, NorthWest Academic Centre, The University of Melbourne, Western Hospital, Melbourne, Australia
    Diabetes Care 34:1133-8. 2011
    ..To examine whether serum 25-hydroxyvitamin D (25OHD) and dietary calcium predict incident type 2 diabetes and insulin sensitivity...
  28. ncbi Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the 'old' versus the 'new' Framingham equation
    Ella Zomer
    Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia
    Eur J Cardiovasc Prev Rehabil 18:115-20. 2011
    ..We sought to determine the differences between the most commonly used Framingham equation from 1991 and the 2008 version through their application to a contemporary Australian population...
  29. ncbi Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study
    Anna Peeters
    Department of Epidemiology and Preventive Medicine, Monash University, Victoria, Australia
    Arch Ophthalmol 126:1554-60. 2008
    ..To examine the association between changes in waist-hip ratio (WHR), a measure of abdominal obesity, and age-related macular degeneration (AMD)...
  30. ncbi Utility-based quality of life associated with overweight and obesity: The australian diabetes, obesity, and lifestyle study
    Catherine L Keating
    Deakin Health Economics, Deakin University, Melbourne, Australia
    Obesity (Silver Spring) 21:652-5. 2013
    ..This study aimed to estimate utility-based quality of life (UQoL) differences between healthy body weight and excess body weight categories...
  31. ncbi The association between dairy food intake and the incidence of diabetes in Australia: the Australian Diabetes Obesity and Lifestyle Study (AusDiab)
    Narelle M Grantham
    Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    Public Health Nutr 16:339-45. 2013
    ..The aim of the present analysis was to investigate if dairy food intake independently reduces the risk of diabetes...
  32. ncbi Novel biomedical risk markers for cardiovascular disease
    Dianna J Magliano
    Department of Epidemiology and Preventive Medicine, Central and Eastern Clinical School, Monash University, Melbourne, Victoria, Australia
    J Cardiovasc Risk 10:41-55. 2003
    ..This review will examine the evidence for the roles of key novel risk markers in cardiovascular disease, against criteria which define causality as well as potential clinical utility...